Kowa Co. Ltd. (Osaka)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3292900002
JPY
805.00
6 (0.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 24.76%

 
2

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 24.76%

 
3

Healthy long term growth as Operating profit has grown by an annual rate 51.85%

 
4

Flat results in May 25

5

With ROE of 20.73%, it has a expensive valuation with a 1.34 Price to Book Value

6

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 4,017 Million (Micro Cap)

stock-summary
P/E

6.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.43

stock-summary
Return on Equity

17.05%

stock-summary
Price to Book

1.37

Revenue and Profits:
Net Sales:
1,763 Million
(Quarterly Results - May 2025)
Net Profit:
122 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.23%
0%
-1.23%
6 Months
4.27%
0%
4.27%
1 Year
-17.18%
0%
-17.18%
2 Years
-41.41%
0%
-41.41%
3 Years
17.18%
0%
17.18%
4 Years
-13.53%
0%
-13.53%
5 Years
-12.6%
0%
-12.6%

Kowa Co. Ltd. (Osaka) for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.32%
EBIT Growth (5y)
51.85%
EBIT to Interest (avg)
31.37
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
1.92
Tax Ratio
35.53%
Dividend Payout Ratio
8.28%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.78%
ROE (avg)
24.76%
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
1.34
EV to EBIT
3.27
EV to EBITDA
2.55
EV to Capital Employed
1.61
EV to Sales
0.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
49.13%
ROE (Latest)
20.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,763.00",
          "val2": "1,570.40",
          "chgp": "12.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "260.90",
          "val2": "247.20",
          "chgp": "5.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.60",
          "val2": "3.60",
          "chgp": "27.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.10",
          "val2": "2.40",
          "chgp": "-54.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "121.60",
          "val2": "89.40",
          "chgp": "36.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.90%",
          "val2": "113.10%",
          "chgp": "-2.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is -0.55% vs 2.16% in Feb 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is -12.35% vs 63.17% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,368.50",
          "val2": "6,404.00",
          "chgp": "-0.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,024.30",
          "val2": "1,164.60",
          "chgp": "-12.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "15.70",
          "val2": "20.20",
          "chgp": "-22.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "43.00",
          "val2": "-36.40",
          "chgp": "218.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "633.70",
          "val2": "723.00",
          "chgp": "-12.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "125.20%",
          "val2": "148.10%",
          "chgp": "-2.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - QoQstock-summary
May'25
Nov'24
Change(%)
Net Sales
1,763.00
1,570.40
12.26%
Operating Profit (PBDIT) excl Other Income
260.90
247.20
5.54%
Interest
4.60
3.60
27.78%
Exceptional Items
1.10
2.40
-54.17%
Consolidate Net Profit
121.60
89.40
36.02%
Operating Profit Margin (Excl OI)
90.90%
113.10%
-2.22%
USD in Million.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Feb'25stock-summary
Feb'25
Feb'24
Change(%)
Net Sales
6,368.50
6,404.00
-0.55%
Operating Profit (PBDIT) excl Other Income
1,024.30
1,164.60
-12.05%
Interest
15.70
20.20
-22.28%
Exceptional Items
43.00
-36.40
218.13%
Consolidate Net Profit
633.70
723.00
-12.35%
Operating Profit Margin (Excl OI)
125.20%
148.10%
-2.29%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Feb 2025 is -0.55% vs 2.16% in Feb 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Feb 2025 is -12.35% vs 63.17% in Feb 2024

stock-summaryCompany CV
About Kowa Co. Ltd. (Osaka) stock-summary
stock-summary
Kowa Co. Ltd. (Osaka)
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available